Key active ingredients include L-Glutathione
A trial from 2023 showed that semaglutide cut the risk of heart attacks and strokes by a fifth in patients with a history of cardiovascular disease
Education of injection and dosing of the product should be done by individuals/pharmacy dispensing the product
The optimal approach depends on individual risk tolerance, budget, and access to various supplier types
The membranes were incubated with primary antibodies LC3A/B (1:1000 dilution, #4108, Cell Signaling Technology, Massachusetts, United States), p62 (1:2000 dilution, ab56416, Abcam, Massachusetts, United States), PINK1 (1:1000 dilution, 23274-1-AP, Proteintech Group, Illinois, United States), Parkin (1:1000 dilution, ab15954, Abcam, Massachusetts, United States), and GAPDH (1:2000 dilution, #2118, Cell Signaling Technology, Massachusetts, United States) overnight at 4C after blocking the membranes with 5% nonfat milk for 1 h, and then incubated with the appropriate IRDye-conjugated secondary antibody (1:10000 dilution, IRDye 800 CW goat anti-rabbit or IRDye 680RD goat anti-mouse, LI-COR Biosciences, Nebraska, United States) and imaged using the LI-COR Odyssey
